The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
10/01/2009
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Document Type:
Grants Notice
Funding Opportunity Number:
W81XWH-09-BCRP-CA
Opportunity Category:
Discretionary
Posted Date:
Oct 01, 2009
Creation Date:
Oct 01, 2009
Original Closing Date for Applications:
Nov 12, 2009
Current Closing Date for Applications:
Nov 12, 2009
Archive Date:
Dec 12, 2009
Funding Instrument Type:
Cooperative Agreement
Grant
Category of Funding Activity:
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
90
Estimated Total Program Funding:
$10,000,000
Award Ceiling:
Award Floor:
CFDA Number(s):
12.420
--
Military Medical Research and Development
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility:
Agency Name
Dept. of the Army -- USAMRAA
Description
The BCRP Concept Award mechanism was first offered in FY99. Since that time, 10,081 Concept Award proposals have been received, and 1073 have been recommended for funding. The Concept Award supports the exploration of a highly innovative new concept or untested theory that addresses an important problem relevant to breast cancer. The Concept Award is not intended to support a logical progression of an already established research project but, instead, supports high-risk studies that have the potential to reveal entirely new avenues for investigation.
Presentation of preliminary data is not allowed. However, a rationale for the proposed work must be provided.
Use of human subjects and human biological substances: Because these awards are designed for preliminary investigations, projects involving human subjects or specimens will not be supported unless they are exempt under Title 32, Code of Federal Regulations, Part 219, Section 101(b)(32 CFR 219.101 [b]). Studies that do not qualify for exempt status will be administratively
withdrawn and will not be funded. For studies using only commercially available unidentified specimens, a Claim of Exemption Form will be requested.
Link to Full Announcement
If you have difficulty accessing the full announcement
electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org
CDMRP Help Desk
Synopsis Modification History
There are currently no modifications for this opportunity.
